Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingsi Zhou

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Nature Methods|May 25, 2023
Development of miniature base editors using engineered IscB nickaseDingyi Han, Qingquan Xiao, Yifan Wang, et al.
Nature Communications|September 16, 2024
Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitationGuoling Li, Xue Dong, Jiamin Luo, et al.
Nature Cell Biology|January 5, 2021
Endogenous promoter-driven sgRNA for monitoring the expression of low-abundance transcripts and lncRNAsNi Gao, Jing Hu, Bingbing He, et al.
Nature Communications|April 11, 2023
Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editingXiangfeng Kong, Hainan Zhang, Guoling Li, et al.
Cell|April 26, 2024
Generation of rat forebrain tissues in miceJia Huang, Bingbing He, Xiali Yang, et al.
Nature Communications|January 27, 2024
Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse modelZhifang Li, Ruochen Guo, Xiaozhi Sun, et al.
Protein & Cell|June 7, 2023
Human 8-cell embryos enable efficient induction of disease-preventive mutations without off-target effect by cytosine base editorYinghui Wei, Meiling Zhang, Jing Hu, et al.
Cell Reports|November 14, 2024
Engineered IscB-ωRNA system with improved base editing efficiency for disease correction via single AAV delivery in miceRuochen Guo, Xiaozhi Sun, Feizuo Wang, et al.
Cell|April 10, 2020
Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in MiceHaibo Zhou, Jinlin Su, Xinde Hu, et al.
Nature Biotechnology|August 11, 2022
High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effectsHuawei Tong, Jia Huang, Qingquan Xiao, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nature Methods|May 25, 2023
Development of miniature base editors using engineered IscB nickaseDingyi Han, Qingquan Xiao, Yifan Wang, et al.
Nature Communications|September 16, 2024
Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitationGuoling Li, Xue Dong, Jiamin Luo, et al.
Nature Cell Biology|January 5, 2021
Endogenous promoter-driven sgRNA for monitoring the expression of low-abundance transcripts and lncRNAsNi Gao, Jing Hu, Bingbing He, et al.
Nature Communications|April 11, 2023
Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editingXiangfeng Kong, Hainan Zhang, Guoling Li, et al.
Cell|April 26, 2024
Generation of rat forebrain tissues in miceJia Huang, Bingbing He, Xiali Yang, et al.
Nature Communications|January 27, 2024
Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse modelZhifang Li, Ruochen Guo, Xiaozhi Sun, et al.
Protein & Cell|June 7, 2023
Human 8-cell embryos enable efficient induction of disease-preventive mutations without off-target effect by cytosine base editorYinghui Wei, Meiling Zhang, Jing Hu, et al.
Cell Reports|November 14, 2024
Engineered IscB-ωRNA system with improved base editing efficiency for disease correction via single AAV delivery in miceRuochen Guo, Xiaozhi Sun, Feizuo Wang, et al.
Cell|April 10, 2020
Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in MiceHaibo Zhou, Jinlin Su, Xinde Hu, et al.
Nature Biotechnology|August 11, 2022
High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effectsHuawei Tong, Jia Huang, Qingquan Xiao, et al.
Pageof 3